For Immediate Release

February 3, 2010

Sumitomo Chemical Reports
Consolidated Financial Results
For the Nine Months Ended December 31, 2009
During the nine months ended December 31, 2009, the Japanese economy showedsome signs of recovery, including a rebound in exports to Asia, but consumer
spending remained sluggish amid worsening employment conditions and capital
investment fell substantially against the backdrop of depressed corporate earnings.
Accordingly, the Sumitomo Chemical Group continued to face a challenging
business environment throughout the period.
Under these circumstances, the Sumitomo Chemical Group’s sales for the ninemonths ended December 31, 2009 were ¥1,142.7 billion, a decrease of ¥310.0 billion
compared with the same period the previous year. The Group’s operating income was¥29.8 billion and ordinary income was ¥19.6 billion, both of which were below thelevels of the same period the previous year, but net income increased to ¥1.2 billion
due to an improvement in extraordinary gains and losses.
The Sumitomo Chemical Group’s financial results by business segment for the ninemonth period are as follows.
Basic Chemicals
Sales of raw materials for synthetic fibers, such as caprolactam, contracted as aresult of a sharp decline in market prices coupled with a drop in feedstock prices.
Sales of aluminum and methyl methacrylate decreased because of a downturn inmarket prices as well as a decrease in shipments. As a result, the segment’s sales fellby ¥62.5 billion compared with the same period the previous year, to ¥143.6 billion.
On the other hand, thanks to better margins, operating income improved by ¥4.1
billion to a loss of ¥3.5 billion yen.
Petrochemicals & PlasticsSales of synthetic resins and petrochemical products decreased because of a sharp
drop in market prices in Asia and selling prices in Japan resulting from a fall in prices
for naphtha and other feedstocks, even though shipment commenced at sales
subsidiaries following the start of operation of Petro Rabigh. Consequently, thesegment’s sales contracted by ¥128.8 billion compared with the same period theprevious year, to ¥337.6 billion. Operating income improved by ¥3.0 billion, to a lossof ¥7.5 billion, due in part to the inventory write-downs posted in the same period theprevious year to reflect the impact of a market price downturn.
Fine Chemicals
Sales of pharmaceutical chemicals and specialty chemicals decreased due to acontraction in shipments and the effects of a stronger yen. As a result, the segment’s
sales fell by ¥16.5 billion compared with the same period the previous year, to ¥49.7billion, and operating income declined by ¥3.8 billion, to a loss of ¥0.2 billion.
IT-related Chemicals
In spite of strong shipments thanks to a recovery in demand in Korea, Taiwan andChina, sales of polarizing film and color filters used in liquid crystal displays (LCD)
were down because selling prices fell below the level of a year earlier. In addition, thevalue of the sales of overseas subsidiaries decreased in yen terms because of theeffects of a stronger yen. As a result, the segment’s sales contracted by ¥65.4 billion,to ¥189.4 billion, and operating income declined by ¥18.5 billion, to a loss of ¥0.8billion, compared with the same period the previous year.
Agricultural Chemicals
Shipments of feed additives and Olyset Net, a long-lasting insecticidal mosquito net,remained solid. As for crop protection chemicals, shipments of herbicides continued
to be strong in overseas markets. Fertilizer sales, however, declined because of adrop in selling prices as well as a decrease in shipments resulting from the effort toreduce inventories in the market. The value of the sales of overseas subsidiaries
decreased owning to the appreciation of the yen. Consequently, the segment’s sales
were down by ¥15.2 billion, to ¥150.1 billion, while operating income increased by¥0.5 billion, to ¥15.9 billion, compared with the same period the previous year.
Pharmaceuticals
Sales of Amlodin (therapeutic agent for hypertension and angina pectoris) fell due tothe effects from the expiration of its patent. Sales of Gasmotin (gastroprokinetic) andProrenal (vasodilator) as well as of Lonasen (agent for the treatment ofschizophrenia), which was launched last year, increased as a result of continued
sales promotion efforts. Owing to these factors as well as the contribution of
Sumitomo Pharmaceuticals (Suzhou) Co., Ltd., which has been consolidated since
the beginning of the current nine month reporting period, the segment’s sales
increased by ¥1.9 billion from the same period the previous year, to ¥181.8 billion.
Operating income contracted by ¥1.3 billion, to ¥27.6 billion, due to an increase in
expenses for the amortization of actuarial differences for employees’ retirement
benefits.
OthersIn addition to the above six segments, the Sumitomo Chemical Group engages insupplying electrical power and steam, providing services for the design, engineering,and construction management of chemical plants, providing transport andwarehousing, and conducting materials and environmental analysis. The Group also
conducts development and sale activities in new business fields, such as polymer
organic light emitting diodes. The segment’s sales decreased by ¥23.5 billion fromthe same period the previous year, to ¥90.４ billion, and operating income improvedby ¥1.0 billion, to a loss of ¥2.2 billion.
Despite a decline in operating income as well as an increase in equity in losses ofaffiliates, net income rose by ¥0.5 billion, to ¥1.2 billion, as a result of an improvement
in foreign currency exchange losses and gains from the sale of investment securities.
With the acquisition in October 2009 of the US firm Sepracor Inc. by our subsidiary
Dainippon Sumitomo Pharma Co., Ltd. (DSP), Sepracor Inc. and DSP’s US
subsidiaries have been consolidated since the three-month reporting period ended
December 31, 2009. Revenues and expenses of Sepracor Inc. will be reflected in thefinancial results of the Group starting in the three-month reporting period ending
March 31, 2010, in accordance with accounting principles generally accepted inJapan.

Summary of Consolidated Results(1) Results of operations:

Net Sales
Operating Income
Ordinary Income
Income Before Income Taxes
and Minority Interests
Net Income

Net income per 1,000 shares（\24,0161,226（\(2) Financial Position:
Total Assets
Total Net AssetBook Value per 1,000 shares（\（\(3) Cash flows:

Cash flows from operating activities
Cash flows from investing activities
Cash flows from financing activities
Cash and cash equivalents at end of period（\(4) Results of Operations byBusiness Segment:（Net Sales
Basic Chemicals
Petrochemicals & Plastics
Fine Chemicals
IT-related Chemicals
Agricultural Chemicals
Pharmaceuticals
Others\\Operating Income
Basic Chemicals
Petrochemicals & Plastics
Fine Chemicals
IT-related Chemicals
Agricultural Chemicals
Pharmaceuticals
OthersElimination

9 Months ended
December 31，2009*\ Million ）（ US$ 1,000 ）
1,142,661$ 12,406,743
29,833323,920
19,646
213,312\\260,760
13,312）Yen

9 Months ended
December 31，2008（ \ Million ）\1,452,626
42,284
26,169743（$21,560758*）

US$8

As of December 31, 2009*\ Million ）（ US$ 1,000 ）2,390,013$ 25,950,195
790,395
8,581,922Yen）
332,314（$*）
US$3,608（\）

Yen459As of March 31, 2009
（ \ Million ）\2,022,553
775,628（\Yen）
329,744

9 Months ended
December 31，2009*\ Million ）（ US$ 1,000 ）
83,373$905,244(268,057)(2,910,499)
236,9022,572,226
139,041
1,509,674

9 Months ended
December 31，2008（ \ Million ）\29,971(154,897)
113,232
92,4479 Months ended
December 31，2009*\ Million ）（ US$ 1,000 ）9 Months ended
December 31，2008（ \ Million ）143,633
337,59249,712
189,437
150,075
181,797
90,415
1,142,661$

1,559,533
3,665,494
539,761
2,056,862
1,629,479
1,973,909
981,705
12,406,743\(3,538)(7,547)(243)(835)
15,907
27,576(2,207)
720
29,833$(38,415)(81,944)(2,638)(9,066)
172,714
299,414(23,963)
7,818
323,920\$$(Note)*U.S. dollar amounts are translated from yen, for convenience only, at the rate of¥92.10= $1 prevailing on December 31, 2009.

\\206,089
466,362
66,224
254,876
165,285
179,901
113,889
1,452,626(7,665)(10,579)
3,583
17,674
15,452
28,901(3,191)(1,891)42,284